Literature DB >> 29920959

Label-free volumetric imaging of conjunctival collecting lymphatics ex vivo by optical coherence tomography lymphangiography.

Peijun Gong1, Dao-Yi Yu2,3, Qiang Wang1, Paula K Yu2,3, Karol Karnowski1, Morgan Heisler4, Ashley Francke4, Dong An2,3, Marinko V Sarunic4, David D Sampson1,5.   

Abstract

We employ optical coherence tomography (OCT) and optical coherence microscopy (OCM) to study conjunctival lymphatics in porcine eyes ex vivo. This study is a precursor to the development of in vivo imaging of the collecting lymphatics for potentially guiding and monitoring glaucoma filtration surgery. OCT scans at 1300 nm and higher-resolution OCM scans at 785 nm reveal the lymphatic vessels via their optical transparency. Equivalent signal characteristics are also observed from blood vessels largely free of blood (and devoid of flow) in the ex vivo conjunctiva. In our lymphangiography, vessel networks were segmented by compensating the depth attenuation in the volumetric OCT/OCM signal, projecting the minimum intensity in two dimensions and thresholding to generate a three-dimensional vessel volume. Vessel segmentation from multiple locations of a range of porcine eyes (n = 21) enables visualization of the vessel networks and indicates the varying spatial distribution of patent lymphatics. Such visualization provides a new tool to investigate conjunctival vessels in tissue ex vivo without need for histological tissue processing and a valuable reference on vessel morphology for the in vivo label-free imaging studies of lymphatics to follow.
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  aqueous veins; blood vessels; conjunctiva; glaucoma; lymphangiography; lymphatics; optical coherence tomography; speckle decorrelation

Mesh:

Year:  2018        PMID: 29920959     DOI: 10.1002/jbio.201800070

Source DB:  PubMed          Journal:  J Biophotonics        ISSN: 1864-063X            Impact factor:   3.207


  7 in total

1.  Functional, structural, and molecular identification of lymphatic outflow from subconjunctival blebs.

Authors:  Goichi Akiyama; Sindhu Saraswathy; Thania Bogarin; Xiaojing Pan; Ernesto Barron; Tina T Wong; Mika K Kaneko; Yukinari Kato; Young Hong; Alex S Huang
Journal:  Exp Eye Res       Date:  2020-05-06       Impact factor: 3.467

2.  Visual Assessment of Aqueous Humor Outflow.

Authors:  Xiaobin Xie; Goichi Akiyama; Thania Bogarin; Sindhu Saraswathy; Alex S Huang
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2019-03-27

Review 3.  Aqueous humour outflow imaging: seeing is believing.

Authors:  Jong Yeon Lee; Goichi Akiyama; Sindhu Saraswathy; Xiaobin Xie; Xiaojing Pan; Young-Kwon Hong; Alex S Huang
Journal:  Eye (Lond)       Date:  2020-10-15       Impact factor: 3.775

4.  Structural Confirmation of Lymphatic Outflow from Subconjunctival Blebs of Live Human Subjects.

Authors:  Jong Yeon Lee; Gad Heilweil; Phuc Le; Sindhu Saraswathy; Young-Kwon Hong; Christopher A Girkin; Alex S Huang
Journal:  Ophthalmol Sci       Date:  2021-11-15

Review 5.  New Therapeutic Approaches for Conjunctival Melanoma-What We Know So Far and Where Therapy Is Potentially Heading: Focus on Lymphatic Vessels and Dendritic Cells.

Authors:  Jennifer Peil; Felix Bock; Friedemann Kiefer; Rebecca Schmidt; Ludwig M Heindl; Claus Cursiefen; Simona L Schlereth
Journal:  Int J Mol Sci       Date:  2022-01-27       Impact factor: 5.923

6.  Subconjunctival Lymphatics Respond to VEGFC and Anti-Metabolites in Rabbit and Mouse Eyes.

Authors:  Jong Yeon Lee; Jingyi Wu; Yameng Liu; Sindhu Saraswathy; Longfang Zhou; Qianwen Bu; Ying Su; Dongwon Choi; Eunkyung Park; Clemens A Strohmaier; Robert N Weinreb; Young-Kwon Hong; Xiaojing Pan; Alex S Huang
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-09-01       Impact factor: 4.925

Review 7.  Parametric imaging of attenuation by optical coherence tomography: review of models, methods, and clinical translation.

Authors:  Peijun Gong; Mitra Almasian; Gijs van Soest; Daniel de Bruin; Ton van Leeuwen; David Sampson; Dirk Faber
Journal:  J Biomed Opt       Date:  2020-04       Impact factor: 3.170

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.